Cerebral hypoperfusion and amyloid-induced synergistic impairment of hippocampal CA1 synaptic efficacy and spatial memory in young adult rats

Journal of Alzheimer's Disease

Volumn 6, Issue 4, 2004, Pages 355-366

  Sun, Miao Kun ^a,b   Alkon, Daniel L ^a  

^a Blanchette Rockefeller Neurosciences Institute   (United States)

^b Research Building   (United States)

Author keywords

2 vessel occlusion; Alzheimer's disease; Cerebral hypoperfusion; Cognition; Hippocampus; Rats

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN METABOLISM; BRAIN PERFUSION; CELL LOSS; CHOLINERGIC SYSTEM; CONTROLLED STUDY; GABAERGIC SYSTEM; HIPPOCAMPUS; INTERNAL CAROTID ARTERY; LEARNING; MALE; MEMORY DISORDER; NERVE CELL NETWORK; NEUROFIBRILLARY TANGLE; NONHUMAN; PRIORITY JOURNAL; RAT; SENILE PLAQUE; SPATIAL MEMORY; SYNAPSE; VASCULAR AMYLOIDOSIS;

EID: 4644262635     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2004-6402     Document Type: Article

References (97)

1. K.F. Ahrens and W.J. Freeman, Response dynamics of entorhinal cortex in awake, anesthetized, and bulbotomized rats, Brain Res 911 (2001), 193-202.
2. D.L. Alkon, J.-V. Sanchez-Andres, E. Ito, K. Oka, T. Yoshioka and C. Collin, Long-term transformation of an inhibitory into an excitatory GABAergic synaptic response, Proc Natl Acad Sci USA 89 (1992), 11862-11866.
3. + channel cascade, Trends Neurosci 21 (1998), 529-537.
4. D.C. Alsop, J.A. Detre and M. Grossman, Assessment of cerebral blood flow in Alzheimer's disease by spin-labeled magnetic resonance imaging, Ann Neurol 47 (2000), 93-100.
5. E.O. Alvarez and A.M. Banzan, Behavioral effects of GABA in the hippocampal formation: functional interaction with histamine, Behav Brain Res 37 (1990), 133-143.
6. C. Arias, T. Montiel, R. Quiroz-Báez and L. Massieu, β-Amyloid neurotoxicity is exacerbated during glycolysis inhibition and mitochondrial impairment in the rat hippocampus in vivo and in isolated nerve terminals: Implications for Alzheimer's disease, Exp Neurol 176 (2002), 163-174.
7. D. Attwell and C. Iadecola, The neural basis of functional brain imaging signals, Trends Neurosci 25 (2002), 621-625.
8. R.T. Bartus, R.L. III Dean, B. Beer and A.S. Lippa, The cholinergic hypothesis in geriatric memory dysfunction, Science 217 (1982), 408-417.
9. M. Blatow, A. Rozov, I. Katona, S.G. Hormuzdi, A.H. Meyer and H. Monyer, A novel network of multipolar bursting interneurons generates theta frequency oscillations in neocortex, Neuron 38 (2003), 805-817.
10. B. Bontempi, C. Laurent-Demir, C. Destrade and R. Jaffard. Time-dependent reorganization of brain circuitry underlying long-term memory storage, Nature 400 (1999), 671-675.
11. H. Braak and E. Braak, Age, neurofibrillary changes, A-beta and onset of Alzheimer's disease, Neurosci Lett 210 (1996), 87-90.
12. H. Braak and E. Braak, Frequency of stages of Alzheimer-related lesions in different age categories, Neurobiol Aging 4 (1997), 351-357.
13. S. Brenowitz, J. David and L. Trussell, Enhancement of synaptic efficacy by presynaptic GABA(B) receptor, Neuron 20 (1998), 135-141.
14. L. Brodin, L. Bakeeval and O. Shupliakov, Presynaptic mitochondria and the temporal pattern of neurotransmitter release, Philos Trans R So Lond B Biol Sc 354 (1999), 365-372.
15. E.H. Buhl, K. Halasy and P. Somogyi, Diverse sources of hippocampal unitary inhibitory postsynaptic potentials and the number of synaptic release sites, Nature 368 (1994), 823-828.
16. A. Cada, J.C. de la Torre and F. Gonzalez-Lima, Chronic cerebrovascular ischemia in aged rats: effects of brain metabolic capacity and behavior, Neurobiol Aging 21 (2000), 225-233.
17. P. Celsis, A. Agniel, D. Cardebat, J.F. Demonet, P. Qusset and M. Puel, Age related cognitive decline: a clinical entity? A longitudinal study of cerebral blood flow and memory performance, J Neurol Neurosurg Psychiatry 87 (1997), 469-480.
18. S.R. Cobb, E.H. Buhl, K. Halasy, O. Paulsen and P. Somogyi, Synchronization of neuronal activity in hippocampus by individual GABAergic interneurons, Nature 378 (1995), 75-78.
19. A.E. Cole and R.A. Nicoll, Characterization of a slow cholinergic post-synaptic potential recorded in vitro from rat hippocampal pyramidal cells, J Physiol Lond 352 (1984), 173-188.
20. C. Collin, W.A. Devane, D. Dahl, C.-J. Lee, J. Axelrod and D.L. Alkon, Long-term synaptic transmission of hippocampal CA1 γ-aminobutyric acid synapses and the effect of anandamide, Proc Natl Acad Sci USA 92 (1995), 10167-10171.
21. G.L. Collingridge and R.A. Lester, Excitatory amino acid receptors in the vertebrate central nervous system, Pharmacol Rev 41 (1989), 14-120.
22. G.I. de Jong, E. Farkas, C.M. Stienstra, J.R. Plass, J.N. Keijser, J.C. de la Torre and P.G. Luiten, Cerebral hypoperfusion yields capillary damage in the hippocampal CA1 area that correlates with spatial memory impairment, Neuroscience 91 (1999), 203-210.
23. J.C. de la Torre, Impaired cerebromicrovascular perfusion. Summary of evidence in support of its causality in Alzheimer's disease, Ann N Y Acad Sci 924 (2000), 136-152.
24. J.C. de la Torre and T. Fortin, A chronic physiological rat model of dementia, Behav Brain Res 63 (1994), 35-40.
25. J.C. de la Torre and G.B. Stefano, Evidence that Alzheimer's disease is a microvascular disorder: the role of constitutive nitric oxide, Brain Res Rev 34 (2000), 119-136.
26. J.C. de la Torre, T. Fortin, G.A.S. Park, K. Butler, P. Kozlowski, D. Pappas, H. de Socarraz, J. Saunders and M. Richard, Chronic cerebrovascular insufficiency induces dementia-like deficits in aged rats, Brain Res 582 (1992), 186-195.
27. J.C. de la Torre, T. Fortin, G.A.S. Park, P. Saunders, P. Kozlowski, K. Butler, H. de Socarraz, B. Pappas and M. Richard, Aged but not young rats develop metabolic, memory deficits after chronic brain ischemia, Neurol Res 14 (1992), 177-180.
28. J.C. de la Torre, A. Cada, N. Nelson, G. Davis, R.J. Sutherland and F. Gonzalez-Lima, Reduced cytochrome oxidase and memory dysfunction after chronic brain ischemia in aged rats, Neurosci Lett 223 (1997), 165-168.
29. L. Descarries, V. Gisiger and M. Steriade, Diffuse transmission by acetylcholine in the CNS, Prog Neurobiol 53 (1997), 603-625.
30. D.I. Dominguez and B. de Strooper, Novel therapeutic strategies provide the real test for the amyloid hypothesis of Alzheimer's disease, Trends Phnarmacol Sci 23 (2002), 324-330.
31. E. Farkas and P.G.M. Luiten, Cerebral microvascular pathology in aging and Alzheimer's disease, Prog Neurobiol 64 (2001), 575-611.
32. A. Favit, M. Grimaldi, T.J. Nelson and D.L. Alkon, Alzheimer's specific effects of soluble beta-amyloid on protein kinase C-alpha and - gamma degradation in human fibroblasts, Proc Natl Acad Sci USA 95 (1998), 5562-5567.
33. R.S.J. Frackowiak, Cerebral imaging and function in the dementias, in: Aging and the Brain, R.D. Terry, ed., Raven Press, New York, 1988, pp. 89-107.
34. J. Giacchino, J.R. Criado, D. Ganes and S. Henriksen, In vivo synaptic transmission in young and aged amyloid precursor protein transgenic mice, Brain Res 876 (2000), 185-190.
35. A.T. Gulledge and G.J. Stuart, Excitatory actions of GABA in the cortex, Neuron 37 (2003), 299-309.
36. Z. He, S. Ibayashi, H. Sugimori and K. Sadoshima, Age-related ischemia in the brain after carotid artery occlusion - collateral blood flow and brain metabolism, Neurochem Res 22 (1997), 37-42.
37. W.D. Heiss, B. Szelies, J. Kessler and K. Herholz, Abnormalities of energy metabolism in Alzheimer's disease studied with PET, Ann New York Acad Sci 649 (1991), 65-71.
38. C. Hirsch, P. Bartenstein, S. Minoshima, D. Mosch, F. Willoch, K. Buch, D. Schad, M. Schwaiger and A. Kurz, Reduction of regional cerebral blood flow and cognitive impairment in patients with Alzheimer's disease: Evaluation of an observer-independent analytic approach, Dement Geriatr Cogn Disord 8 (1997), 98-104.
39. A.Y. Hsia, E. Masliah, L. McConlogue, G.Q. Yu, G. Tasuno, K. Hu, D. Kholodenko, R.C. Malenka and R.A. Nicoll, Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models, Proc Natl Acad Sci USA 96 (1999), 3228-3233.
40. P.T. Huerta and J.E. Lisman, Bidirectional synaptic plasticity induced by a single burst during cholinergic theta oscillation in CA1 in vitro, Neuron 15 (1995), 1053-1063.
41. M.C. Irizarry, M. McNamara, K. Fedorchak, K. Hsiao and B.T. Hyman, APPSw transgenic mice develop age-related deposits and neuropil abnormalities, but no neuronal loss in CA1, J Neuropathol Exp Neurol 56 (1997), 965-973.
42. K.A. Jellinger and C. Stadelmann, Problems of cell death in neurodegeneration and Alzheimer's disease, J Alzheimers Dis 3 (2001), 31-40.
43. K.A. Johnson, K. Jones, B.L. Holman, J. Becker, P.A. Spiers, A. Satlin and M.S. Albert, Preclinical prediction of Alzheimer's disease using SPECT, Neurology 50 (1998), 1563-1571.
44. K. Kaila, J. Voipio, P. Paalasmaa, M. Paternack and R.A. Deisz, The role of bicarbonate in GABAA receptor-mediated IPSPs of rat neocortical neurons, J Physiol Lond 464 (1993), 273-289.
45. + transient, J Neurosci 17 (1997), 7662-7672.
46. R.N. Kalaria, The role of cerebral ischemia in Alzheimer's disease, Neurol Aging 21 (2000), 321-330.
47. M. Kamermans and F. Werblin, GABA-mediated positive autofeedback loop controls horizontal cell kinetics in tiger salamander retina, J Neurosci 12 (1992), 2451-2563.
48. S. Kar, D. Seto, P. Gaudreau and R. Quirion, β-Amyloid-related peptides inhibit potassium-evoked acetylcholine release from rat hippocampal formation, J Neurosci 16 (1996), 1034-1040.
49. S. Kar, A.M. Issa, D. Seto, D.S. Auld, B. Collier and R. Quirion, Amyloid β-peptide inhibits high-affinity choline uptake and acetylcholine release in rat hippocampal slices, J Neurochem 70 (1998), 2179-2187.
50. J.F. Kelly, K. Furukawa, S.W. Baerger, M.R. Rengen, R.J. Mark, E.M. Blanc, G.S. Roth and M.P. Mattson, Amyloid β-peptide disrupts carbachol-induced muscarinic cholinergic signal transduction in cortical neurons, Proc Natl Acad Sci USA 93 (1996), 6753-6758.
51. J.M. Kornhauser and M.E. Greenberg, A kinase to remember: dual roles for MAP kinase in long-term memory, Neuron 18 (1997), 839-842.
52. 2+]I rise in fetal rat motoneurons in situ, J Neurosci 20 (2000), 7905-7913.
53. M.P. Mattson and W. Duan, Apoptotic biochemical cascades in synaptic compartments: Role in adaptive plasticity and neurodegenerative disorders, J Neurosci Res 58 (1999), 152-166.
54. N. Meiri, M.-K. Sun, Z. Segal and D.L. Alkon, Memory and long-term potentiation (LTP) dissociated: normal spatial memory despite CA1 LTP elimination with Kv1.4 antisense, Proc Natl Acad Sci USA 95 (1998), 15037-15042.
55. H.B. Michelson and P.K.S. Wong, Excitatory synaptic responses mediated by GABAA receptors in the hippocampus, Science 253 (1991), 1420-1423.
56. R. Mielke and W.D. Heiss, Positron emission tomography for diagnosis of Alzheimer's disease and vascular dementia, J Neural Transm 53 (1998), 237-250.
57. D. Moechars, K. Dewachter, K. Lorent, D. Reverse, V. Baekelandt, A. Naidu, I. Tesseur, K. Spittaels, C.V. Haute, F. Checler, E. Godaux, B. Cordell and F. Van Leuven, Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain, J Biol Chem 274 (1999), 6483-6492.
58. A.L. Morrow, P.D. Suzdak, J.W. Karanian and S.M. Paul, Chronic ethanol administration alters gamma-aminobutyric acid, pentobarbital and ethanol-mediated 36Cl-uptake in cerebral cortical synaptoneurosomes, J Pharmacol Exp Ther 246 (1988), 158-164.
59. M. Moscovitch and L. Nadel, Consolidation and the hippocampal complex revisited: in defense of the multiple-trace model, Curr Opin Neurobiol 8 (1998), 297-300.
60. 1-42 in wild-type human amyloid precursor transgenic mice: synaptotoxicity without plaque formation, J Neurosci 20 (2000), 4050-4058.
61. J. Naslund, V. Haroutunian, R. Mohs, K.L. Davis, P. Davies, P. Greengard and J.D. Buxbaum, Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline, JAMA 283 (2000), 1571-1577.
62. J.A.R. Nicoll, D. Wilkinson, C. Holmes, P. Steart, H. Markham and R.O. Weller, Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report, Nat. Med 9 (2003), 448-452.
63. B.A. Pappas, J.C. de la Torre, C. Davidson, M. Keyes and T. Fortin, Chronic reduction of cerebral blood flow in the adult rat: late emerging CA1 cell loss and memory function, Brain Res 708 (1996), 50-58.
64. D. Paris, T Town, T Parker, J. Humphrey and M. Mullan, A beta vasoactivity: an inflammatory reaction, Ann NY Acad Sci 903 (2000), 97-109.
65. O. Paulsen and E.I. Moser, A model of hippocampal memory encoding and retrieval: GABAergic control of synaptic plasticity, Trends Neurosci 21 (1998), 273-278.
66. J.W. Pettegrew, W.E. Klunk, K. Panchalingam, R.J. McClure and J.A. Stanley, Magnetic resonance spectroscopic changes in Alzheimer's disease, Ann NY Acad Sci 826 (1997), 282-306.
67. P. Pietrini, M.L. Furey, G.E. Alexander, M.J. Mentis, A. Dani, M. Guazzelli, S.I. Rapoport and M.B. Shapira, Association between brain functional failure and dementia severity in Alzheimer's disease: resting versus stimulation PET study, Am J Psychiat 156 (1999), 470-473.
68. S.G. Potkin, R. Anand, K. Fleming, G. Alva, D. Keator, D. Carreon, J. Messina, J.C. Wu, R. Hartman and J.H. Fallon, Brain metabolic and clinical effects of rivastigmine in Alzheimer's disease, Int J Neuropsychopharmacol 4 (2001), 223-230.
69. J.A. Rhodin and T. Thoman, A vascular connection to Alzheimer's disease, Microcirculation 8 (2001), 207-220.
70. G. Rodriguez, F. Nobili, G. Rocca, F. De Carli, M.V. Gianelli and G. Rosadini, Quantitative electroencephalography and regional cerebral blood flow: discriminant analysis between Alzheimer's patients and healthy controls, Dement D Geriatr Cogn Disord 9 (1998), 274-283.
71. 11C] methionine accumulation in probable Alzheimer's disease using positron emission tomography, J Cereb Blood Flow Metab 16 (1996), 399-408.
72. D.J. Selkoe, Alzheimer's disease: genes, proteins, and therapy, Physiol Rev 81 (2001), 741-766.
73. D.J. Selkoe, Alzheimer's disease is a synaptic failure, Science 298 (2002), 789-791.
74. L. Siklós, M. Rickmann, F. Joó, W.J. Freeman and J.R. Wolff, Chloride is preferentially accumulated in a subpopulation of dendrites and periglomerular cells of the main olfactory bulb in adult rats, Neuroscience 64 (1995), 165-172.
75. G.W. Small and F. Leiter, Neuroimaging for diagnosis of dementia, J Clin Psychiat 59(11) (1998), 4-7.
76. G.S. Smith, M.J. de Leon, A.E. George, A. Kluger, N.D. Volkow, T. McRae, J. Golomb, S.H. Ferris, B. Reisberg, J. Ciaravino and M.E. La Regina, Topography of cross-sectional and longitudinal glucose metabolic deficits in Alzheimer's disease, Arch Neurol 49 (1992), 1142-1150.
77. M. Sone, H. Sei, Y. Morita, T. Ogura and S. Sone, The effects of acetazolamide on arterial pressure variability during REM sleep in the rat, Physiol Behav 63 (1998), 213-218.
78. K.J. Staley, B.L. Soldo and W.R. Proctor, Ionic mechanisms of neuronal excitation by inhibitory GABAA receptors, Science 269 (1995), 977-981.
79. V. Stein and R.A. Nicoll, GABA generates excitement, Neuron 37 (2003), 375-378.
80. M.-K. Sun, Pharmacology of reticulospinal vasomotor neurons in cardiovascular regulation, Pharmacol Rev 48 (1996), 465-494.
81. M.-K. Sun and D.L. Alkon, Carbonic anhydrase gating in cognition: memory therapy and enhancement, Trends Pharmacol Sci 23 (2002), 83-89.
82. 25-35, J Neurophysiol 87 (2002), 2441-2449.
83. M.-K. Sun, T.J. Nelson, H. Xu and D.L. Alkon, Calexcitin transformation of GABAergic synapses: from excitation filter to amplifier, Proc Natl Acad Sci USA 96 (1999), 7023-7028.
84. M.-K. Sun, W.-O. Zhao, T.J. Neslon and D.L. Alkon, Theta rhythm of CA1 hippocampal neuron activity: gated by GABAergic synaptic depolarization, J Neurophysiol 85 (2001), 269-279.
85. M.-K. Sun, D. Dahl and D.L. Alkon, Heterosynaptic transformation of GABAergic gating in the hippocampus and effects of carbonic anhydrase inhibition, J Pharmacol Expl Ther 296 (2001), 811-817.
86. M.-K. Sun, H. Xu and D.L. Alkon, Protection of synaptic function, spatial learning, and memory from transient hypoxia in rats, J Pharmacol Exp Ther 300 (2002), 408-416.
87. B. Szelies, K. Herholz, G. Pawlik, C. Beli, K. Wienhard and W.D. Heiss, Cerebral glucose metabolism in presenile dementia of the Alzheimer type: follow-up of therapy with muscarinergic choline agonists, Fortschritte der Neurologie-Psychiatrie 54 (1986), 364-373.
88. C.D. Tesche and J. Karhu, Theta oscillations index human hippocampal activation during a working memory task, Proc Natl Acad Sci USA 97 (2000), 919-924.
89. T. Thomas, G. Thomas, C. McLendon, T. Sutton and M. Mullan, β-Amyloid-mediated vasoactivity and vascular endothelial damage, Nature 380 (1996), 168-171.
90. L.T. Thompson and P.J. Best, Place cells and silent cells in the hippocampus of freely-behaving rats, J Neurosci 9 (1989), 2382-2390.
91. P.J. Tienari, B. De Strooper, E. Ikonen, M. Simons, A. Weidemann, C. Czech, T. Hartmann, N. Ida, G. Multhaup, C.L. Masters, F. Van Leuven, K. Beyreuther and C.G. Dotti, The β-amyloid domain is essential for axonal sorting of amyloid precursor protein, EMBO J 15 (1996), 5218-5229.
92. G. Waldemar, P. Hogh and O.B. Paulson, Functional brain imaging with single-photon emission computed tomography in the diagnosis of Alzheimer's disease, Int Psychogeriatr 9 (Suppl. 1) (1997), 223-227.
93. D. Waldvogel, P. van Gelderen, W. Muellbacher, U. Ziemann, I. Immisch and M. Hallett, The relative metabolic demand of inhibition and excitation, Nature 406 (2000), 995-998.
94. 1-42 binds to α7 nicotinic acetylcholine receptor with high affinity, J Biol Chem 275 (2000), 5626-5632.
95. 1-42 binds selectively and with picomolar affinity to α7 nicotinic acetylcholine receptors, J Neurochem 75 (2000), 1155-1161.
96. J.M. Williams, V.L. Thompson, S.E. Mason-Parker, W.C. Abraham and W.P. Tate, Synaptic activity-dependent modulation of mitochondrial gene expression in the rat hippocampus, Mol Brain Res 60 (1998), 50-56.
97. J. Winson, Loss of hippocampal theta rhythm results in spatial memory deficit in the rat, Science 201 (1978), 160-163.